JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pueyo, F. J.
Right arrow Articles by Saez, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pueyo, F. J.
Right arrow Articles by Saez, A.

Anesthesia & Analgesia, Vol 83, 117-122, Copyright © 1996 by International Anesthesia Research Society


GENERAL ARTICLES

Combination of ondansetron and droperidol in the prophylaxis of postoperative nausea and vomiting

FJ Pueyo, F Carrascosa, L Lopez, MJ Iribarren, F Garcia-Pedrajas and A Saez
Department of Anesthesiology and Critical Care, University Clinic, School of Medicine, University of Navarra, Pamplona, Spain.

The aim of this study was to compare the efficacy and safety of ondansetron plus droperidol with each drug alone or placebo in the prevention of postoperative nausea and vomiting (PONV). One hundred females, aged 18-65 yr, ASA physical status I-II, undergoing general anesthesia for elective abdominal surgery were included in a prospective, double-blind, placebo-controlled, randomized study. A standardized anesthetic technique and postoperative analgesia (ketorolac plus patient-controlled analgesia [PCA] with morphine) were used in all patients. Patients were randomly assigned to receive placebo (Group 1, n = 25), droperidol 2.5 mg with induction of anesthesia and 1.25 mg 12 h later (Group 2, n = 25), ondansetron 4 mg with induction (Group 3, n = 25), and ondansetron plus droperidol at the same doses as Groups 3 and 2, respectively (Group 4, n = 25). A complete response, defined as no PONV in 48 h, occurred in 28% of patients in Group 1, 60% in Group 2 (P < 0.05 vs Group 1), 56% in Group 3 (P < 0.05 vs Group 1), and 92% in Group 4 (P < 0.01 vs Groups 1, 2, and 3). Sedation was significantly greater with droperidol (Groups 2 and 4) for 12 h postoperatively. In conclusion, the combination of ondansetron plus droperidol was more effective than each antiemetic alone or placebo in the prevention of PONV in women undergoing elective abdominal surgery.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
L. Grecu, E. A. Bittner, J. Kher, S. E. Smith, and C. E. Rosow
Haloperidol Plus Ondansetron Versus Ondansetron Alone for Prophylaxis of Postoperative Nausea and Vomiting
Anesth. Analg., May 1, 2008; 106(5): 1410 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. T. V. Chan, K. C. Choi, T. Gin, P. T. Chui, T. G. Short, P. M. Yuen, A. H. Y. Poon, C. C. Apfel, and T. J. Gan
The Additive Interactions Between Ondansetron and Droperidol for Preventing Postoperative Nausea and Vomiting
Anesth. Analg., November 1, 2006; 103(5): 1155 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
A. S. Habib, H. E. El-Moalem, and T. J. Gan
The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials: [L'efficacite de la combinaison des antagonistes des recepteurs 5-HT3 et du droperidol ou de la dexame- thasone est similaire pour prevenir les NVPO. Une meta-analyse d'essais randomises et controles]
Can J Anesth, April 1, 2004; 51(4): 311 - 319.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. J. Gan
Postoperative Nausea and Vomiting--Can It Be Eliminated?
JAMA, March 13, 2002; 287(10): 1233 - 1236.
[Full Text] [PDF]


Home page
BMJHome page
C. J. Ryan, N. Tabet, R. Howard, D. Meagher, J Haines, P Barclay, and T Wauchob
Optimising management of delirium
BMJ, June 30, 2001; 322(7302): 1602 - 1602.
[Full Text]


Home page
Anesth. Analg.Home page
P. E. Scuderi, R. L. James, L. Harris, and G. R. Mims III
Multimodal Antiemetic Management Prevents Early Postoperative Vomiting After Outpatient Laparoscopy
Anesth. Analg., December 1, 2000; 91(6): 1408 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
Editorial: Postoperative nausea and vomiting--time for balanced antiemesis?
Br. J. Anaesth., November 1, 2000; 85(5): 675 - 677.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
A. B. Ahmed, G. J. Hobbs, and J. P. Curran
Randomized, placebo-controlled trial of combination antiemetic prophylaxis for day-case gynaecological laparoscopic surgery{dagger}
Br. J. Anaesth., November 1, 2000; 85(5): 678 - 682.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
P. S. Loewen, C. A. Marra, and P. J. Zed
5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting
Can J Anesth, October 1, 2000; 47(10): 1008 - 1018.
[Abstract] [PDF]


Home page
Canadian J. AnesthesiaHome page
O. Wu, S. E. Belo, and G. Koutsoukos
Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy
Can J Anesth, June 1, 2000; 47(6): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
I. Henzi, J. Sonderegger, and M. R. Tramer
Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting
Can J Anesth, June 1, 2000; 47(6): 537 - 551.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. B. Domino, E. A. Anderson, N. L. Polissar, and K. L. Posner
Comparative Efficacy and Safety of Ondansetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting: A Meta-Analysis
Anesth. Analg., June 1, 1999; 88(6): 1370 - 1370.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. R Tramèr, D J. M Reynolds, R A. Moore, and H. J McQuay
When placebo controlled trials are essential and equivalence trials are inadequate
BMJ, September 26, 1998; 317(7162): 875 - 880.
[Full Text]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1996 by the International Anesthesia Research Society.